Is disease-modifying therapy use in multiple sclerosis a risk factor during the COVID-19 pandemic? A large cohort study

Journal of Health Policy and Outcomes Research · Published 2024-04-26 · DOI 10.7365/jhpor.2024.1.5

Authors being retrieved — see the publisher record. https://doi.org/10.7365/jhpor.2024.1.5

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2024

Related articles